Catalyst Wire Dossier Catalyst Wire Dossier

AVT05

golimumab · Alvotech Swiss AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVT05, covering 2025-05-28 to 2025-05-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants [Phase 1]

See pricing